Multimedia
 | Media file 1: Ultrasound in a patient with von Gierke disease (glycogen storage disease type 1) and several hepatic adenomas (same patient in Images 1-9). This image shows a mass in the right lobe of the liver that is predominantly isoechoic relative to the liver parenchyma and contains a small, round, hypoechoic component. The 2 masses appear slightly hypoechoic. |
 | Media file 2: T2-weighted fat-saturated fast spin-echo axial magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows 2 heterogeneous, hyperintense masses in the right lobe of the liver. |
 | Media file 3: T1-weighted in-phase magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image demonstrates normal hepatic signal intensity that is hyperintense relative to the spleen. Two heterogeneous masses that represent hepatic adenomas are seen in the right lobe and are slightly hypointense relative to the liver parenchyma. |
 | Media file 4: T1-weighted out-of-phase magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows abnormal low signal intensity of the liver, hypointense relative to the spleen, representing fatty infiltration of the liver. The hepatic adenomas are heterogeneous and slightly hyperintense relative to the fatty liver. |
 | Media file 5: Single-shot fast spin-echo T2-weighted coronal magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows a hyperintense mass in the right lobe of the liver and an additional hyperintense mass in the inferior tip of the liver, representing a third hepatic adenoma. |
 | Media file 6: Fat-saturated 3-dimensional T1-weighted gradient-echo magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows 2 heterogeneous, slightly hyperintense masses in the right lobe of the liver. |
 | Media file 7: Gadolinium-enhanced fat-saturated 3-dimensional T1-weighted gradient-echo magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows intense enhancement of the hepatic adenomas. |
 | Media file 8: Gadolinium-enhanced fat-saturated 3-dimensional T1-weighted gradient-echo magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows that the hepatic adenoma remains hyperintense relative to the liver parenchyma. |
 | Media file 9: Gadolinium-enhanced fat-saturated 3-dimensional T1-weighted gradient-echo magnetic resonance image in a patient with von Gierke disease (same patient in Images 1-9). This image shows that the hepatic adenoma remains hyperintense relative to the liver parenchyma. |
 | Media file 10: Noncontrast computed tomography scan in a 41-year-old woman with a history of oral contraceptive use (same patient in Images 10-12). This image demonstrates a heterogeneous, low-attenuation mass in the right lobe of the liver, a hepatic adenoma. |
 | Media file 11: Contrast-enhanced computed tomography scan in the portal venous phase in a 41-year-old woman with a history of oral contraceptive use (same patient in Images 10-12). This image demonstrates a heterogeneous, enhancing mass, a hepatic adenoma, predominantly isoattenuating relative to the liver with areas of low attenuation. |
 | Media file 12: Technetium-99m (99mTc)–labeled red blood cell single-photon emission computed tomography scintigraphy in a 41-year-old woman with a history of oral contraceptive use (same patient in Images 10-12). This image shows no demonstrable activity in the hepatic mass, indicating that it does not represent a hemangioma. |
More on Hepatic Adenoma |
| Overview: Hepatic Adenoma |
| Imaging: Hepatic Adenoma |
| Follow-up: Hepatic Adenoma |
 Multimedia: Hepatic Adenoma |
| References |
| Further Reading |
| « Previous Page |
References
Micchelli ST, Vivekanandan P, Boitnott JK, et al. Malignant transformation of hepatic adenomas. Mod Pathol. Apr 2008;21(4):491-7. [Medline].
Ibrahim S, Chen CL, Wang SH, et al. Liver resection for benign liver tumors: indications and outcome. Am J Surg. Jan 2007;193(1):5-9. [Medline].
Herman P, Pugliese V, Machado MA, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg. Mar 2000;24(3):372-6. [Medline].
Kume N, Suga K, Nishigauchi K, Shimizu K, Matsunaga N. Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging. Clin Nucl Med. Dec 1997;22(12):825-31. [Medline].
Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg. Oct 1996;62(10):825-9. [Medline].
Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Intern Med. Mar 15 1989;110(6):489-90. [Medline].
Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. Aug 17 1979;242(7):644-8. [Medline].
Hill MA, Albert T, Zieske A, Levine EA. Successful resection of multifocal hepatic adenoma during pregnancy. South Med J. Mar 1997;90(3):357-61. [Medline].
Veteläinen R, Erdogan D, de Graaf W, ten Kate F, Jansen PL, Gouma DJ, et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int. Apr 2008;28(4):499-508. [Medline].
Casillas VJ, Amendola MA, Gascue A, et al. Imaging of nontraumatic hemorrhagic hepatic lesions. Radiographics. Mar-Apr 2000;20(2):367-78. [Medline]. [Full Text].
Welch TJ, Sheedy PF 2nd, Johnson CM, et al. Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology. Sep 1985;156(3):593-5. [Medline]. [Full Text].
Weimann A, Ringe B, Klempnauer J, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg. Nov-Dec 1997;21(9):983-90; discussion 990-1. [Medline].
Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, et al. Liver Cell Adenoma: A Multicenter Analysis of Risk Factors for Rupture and Malignancy. Ann Surg Oncol. Jan 8 2009;[Medline].
Ahmad I, Iyer A, Marginean CE, Yeh MM, Ferrell L, Qin L, et al. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma. Hum Pathol. Jan 19 2009;[Medline].
Iyer A, Robert ME, Bifulco CB, Salem RR, Jain D. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance. Hum Pathol. Sep 2008;39(9):1370-7. [Medline].
Wojtowycz M, ed. Handbook of Interventional Radiology and Angiography. 2nd ed. St Louis, Mo: Mosby-Year Book; 1995:77-83.
Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology. Mar 2000;214(3):861-8. [Medline]. [Full Text].
Paulson EK, McClellan JS, Washington K, et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol. Jul 1994;163(1):113-6. [Medline]. [Full Text].
Paley MR, Mergo PJ, Torres GM, Ros PR. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. AJR Am J Roentgenol. Jul 2000;175(1):159-63. [Medline]. [Full Text].
Venkatesh SK, Yin M, Glockner JF, et al. MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol. Jun 2008;190(6):1534-40. [Medline].
Chang SD, Thoeni RF. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement. AJR Am J Roentgenol. May 2008;190(5):1318-23. [Medline].
Giovanoli O, Heim M, Terracciano L, Bongartz G, Ledermann HP. MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol. May 2008;190(5):W290-3. [Medline].
Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology. Dec 1995;22(6):1674-81. [Medline].
Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic Ultrasound. Vol 1. 2nd ed. St Louis, Mo: Mosby-Year Book; 1998:129-30.
Morin SH, Lim AK, Cobbold JF, Taylor-Robinson SD. Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. World J Gastroenterol. Dec 7 2007;13(45):5963-70. [Medline]. [Full Text].
Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. 'False-positive' uptake of FDG in a hepatic adenoma. Clin Nucl Med. Jul 1997;22(7):490-1. [Medline].
Arrivé L, Fléjou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology. Nov 1994;193(2):507-12. [Medline]. [Full Text].
Davis LP, McCarroll K. Correlative imaging of the liver and hepatobiliary system. Semin Nucl Med. Jul 1994;24(3):208-18. [Medline].
Dunphy T. Magnetic resonance imaging of focal liver lesions. Appl Radiol. 2001;30(suppl):69-70.
Further Reading
Clinical studies:
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Keywords
hepatic adenoma, hepatocellular adenoma, liver adenoma, liver tumor, HA, benign liver tumor, benign epithelial tumor of the liver, liver cell adenoma, hepatocellular carcinoma, HCC, focal nodular hyperplasia, FNH, Kupffer cells, Kupffer's cells
